Annual FCF:
-$230.11M-$84.74M(-58.29%)Summary
- As of today, AKRO annual free cash flow is -$230.11 million, with the most recent change of -$84.74 million (-58.29%) on December 31, 2024.
- During the last 3 years, AKRO annual free cash flow has fallen by -$150.43 million (-188.79%).
- AKRO annual free cash flow is now -5151.19% below its all-time high of -$4.38 million, reached on December 31, 2017.
Performance
AKRO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$67.17M-$18.93M(-39.23%)Summary
- As of today, AKRO quarterly free cash flow is -$67.17 million, with the most recent change of -$18.93 million (-39.23%) on September 30, 2025.
- Over the past year, AKRO quarterly free cash flow has increased by +$3.25 million (+4.62%).
- AKRO quarterly free cash flow is now -19773.08% below its all-time high of -$338.00 thousand, reached on March 31, 2018.
Performance
AKRO Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$250.17M+$3.25M(+1.28%)Summary
- As of today, AKRO TTM free cash flow is -$250.17 million, with the most recent change of +$3.25 million (+1.28%) on September 30, 2025.
- Over the past year, AKRO TTM free cash flow has dropped by -$38.53 million (-18.20%).
- AKRO TTM free cash flow is now -73915.09% below its all-time high of -$338.00 thousand, reached on March 31, 2018.
Performance
AKRO TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AKRO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -58.3% | +4.6% | -18.2% |
| 3Y3 Years | -188.8% | -172.8% | -167.0% |
| 5Y5 Years | -545.9% | -392.1% | -322.6% |
AKRO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -188.8% | at low | -200.0% | +4.6% | -170.4% | +4.7% |
| 5Y | 5-Year | -545.9% | at low | -392.1% | +4.6% | -322.6% | +4.7% |
| All-Time | All-Time | -5151.2% | at low | >-9999.0% | +4.6% | >-9999.0% | +4.7% |
AKRO Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$67.17M(-39.2%) | -$250.17M(+1.3%) |
| Jun 2025 | - | -$48.25M(+28.7%) | -$253.42M(+3.5%) |
| Mar 2025 | - | -$67.66M(-0.9%) | -$262.63M(-14.1%) |
| Dec 2024 | -$230.11M(-58.3%) | -$67.09M(+4.7%) | -$230.11M(-8.7%) |
| Sep 2024 | - | -$70.42M(-22.6%) | -$211.64M(-10.8%) |
| Jun 2024 | - | -$57.45M(-63.5%) | -$190.94M(-22.5%) |
| Mar 2024 | - | -$35.14M(+27.7%) | -$155.88M(-7.2%) |
| Dec 2023 | -$145.37M(-57.1%) | -$48.63M(+2.2%) | -$145.37M(-18.9%) |
| Sep 2023 | - | -$49.72M(-122.1%) | -$122.25M(-25.8%) |
| Jun 2023 | - | -$22.39M(+9.1%) | -$97.15M(-3.1%) |
| Mar 2023 | - | -$24.63M(+3.4%) | -$94.27M(-1.9%) |
| Dec 2022 | -$92.52M(-16.1%) | -$25.51M(-3.6%) | -$92.52M(+1.3%) |
| Sep 2022 | - | -$24.62M(-26.2%) | -$93.70M(-12.0%) |
| Jun 2022 | - | -$19.51M(+14.7%) | -$83.69M(+0.6%) |
| Mar 2022 | - | -$22.88M(+14.3%) | -$84.21M(-5.7%) |
| Dec 2021 | -$79.68M | -$26.70M(-82.8%) | -$79.68M(-4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$14.61M(+27.1%) | -$76.39M(-1.3%) |
| Jun 2021 | - | -$20.03M(-9.2%) | -$75.43M(+3.3%) |
| Mar 2021 | - | -$18.35M(+21.6%) | -$77.98M(-9.9%) |
| Dec 2020 | -$70.95M(-99.2%) | -$23.40M(-71.4%) | -$70.95M(-19.8%) |
| Sep 2020 | - | -$13.65M(+39.6%) | -$59.20M(-0.7%) |
| Jun 2020 | - | -$22.58M(-99.6%) | -$58.76M(-41.6%) |
| Mar 2020 | - | -$11.32M(+2.9%) | -$41.50M(-16.5%) |
| Dec 2019 | -$35.63M(-270.2%) | -$11.65M(+11.8%) | -$35.63M(-36.7%) |
| Sep 2019 | - | -$13.21M(-148.3%) | -$26.05M(-76.0%) |
| Jun 2019 | - | -$5.32M(+2.2%) | -$14.80M(-0.5%) |
| Mar 2019 | - | -$5.44M(-162.4%) | -$14.73M(-53.0%) |
| Dec 2018 | -$9.63M(-119.6%) | -$2.08M(-5.8%) | -$9.63M(-27.5%) |
| Sep 2018 | - | -$1.96M(+62.7%) | -$7.55M(-35.1%) |
| Jun 2018 | - | -$5.25M(-1453.6%) | -$5.59M(-1553.6%) |
| Mar 2018 | - | -$338.00K | -$338.00K |
| Dec 2017 | -$4.38M | - | - |
FAQ
- What is Akero Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Akero Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Akero Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Akero Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of AKRO is -$230.11M
What is the all-time high annual free cash flow for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual free cash flow is -$4.38M
What is Akero Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, AKRO annual free cash flow has changed by -$84.74M (-58.29%)
What is Akero Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of AKRO is -$67.17M
What is the all-time high quarterly free cash flow for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly free cash flow is -$338.00K
What is Akero Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, AKRO quarterly free cash flow has changed by +$3.25M (+4.62%)
What is Akero Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of AKRO is -$250.17M
What is the all-time high TTM free cash flow for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM free cash flow is -$338.00K
What is Akero Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, AKRO TTM free cash flow has changed by -$38.53M (-18.20%)